$0.7290
-0.00300-0.41%
At close: -
$0.7002
-0.03-3.95%
After Hours: Jan 31, 7:54 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Oncolytics Biotech in recent months.
Browse guidance and forecast on all stocks.